Home » Topics » Regulatory

Regulatory
RSS

New Risperdal formulation launched

May 8, 2003

Extended-release ciprofloxacin in complicated urinary tract infections

May 8, 2003

Forest seeks label expansion for Lexapro to include panic disorder

May 6, 2003

FDA approves more convenient formulation of Viracept

May 6, 2003

FDA approves Aldurazyme for MPS I

May 5, 2003

Low-dose Premarin receives FDA approval

April 30, 2003

Nippon Boehringer Ingelheim and Sankyo intend to comarket Alesion

April 29, 2003

FDA approves Vigamox

April 22, 2003

Activa Therapy receives humanitarian device exemption for dystonia

April 22, 2003

New Rapamune indication approved

April 15, 2003